This Fund Just Viridian: Key Takeaways for Investors
A major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
A straightforward comparison of the Djia and the S&P 500, focusing on diversification, volatility profiles, and historical performance to guide decision making.
22,615 articlesA major fund recently trimmed its stake in Viridian Therapeutics, signaling potential rotation rather than a verdict ...
Tim Cook used the China Development Forum to stress collaboration with Chinese partners as Beijing intensifies policy...
The European Union and Mercosur clinched a landmark free-trade agreement after 25 years of negotiations, linking 700 ...
A fresh flare in Middle East tensions pushes oil prices higher, elevating Russia’s revenue outlook and prompting inve...
An explosion at a Texas refinery sparked a large smoke plume and led to shelter-in-place orders for nearby communitie...
A big investor recently unloaded $7.8 million worth of Harrow stock. This article breaks down whether that move signa...
March PMI data show slowing U.S. growth with rising costs. Bitcoin reacts nervously, facing renewed macro risk as tra...
Raymond James lifts Valero's price target to $290, arguing sustained refining margins and a structural advantage coul...
A sweeping defense modernization plan totaling $185 billion could lift software-focused players like Palantir as miss...
Insider moves can reveal much about a company’s outlook, but they aren’t a single data point. This article breaks dow...
NVIDIA stock is under pressure as a wave of AI infrastructure spending by the Magnificent Seven tests profits versus ...
Tower Semiconductor is navigating a critical inflection point as it scales SiPho production and expands in Japan, wit...